Prostate cancer Board decisions

The Veteran's claim for service connection for an acquired psychiatric disability, gastroesophageal reflux disease, irritable bowel disease, neuropathy of lower extremities, neuropathy of upper extremities, rhinitis, sinusitis, prostate cancer, bilateral plantar fasciitis, right knee condition (claimed as bilateral knee injuries), and traumatic brain injury is denied due to lack of evidence supporting the presence or relationship of these conditions to service.,The Veteran's claim for secondary service connection for loss of use of a creative organ and sleep apnea related to an acquired psychiatric disability is also denied.

The Veteran's entitlement to an allowance for an automobile or other conveyance and adaptive equipment was denied, while his restoration of severed service connection benefits for prostate cancer was granted. The effective date is not specified.

The Veteran's appeal for service connection for prostate cancer, thyroid disease, and scar status post thyroidectomy is dismissed as the claims are moot due to a grant of service connection for neoplasms of the male reproductive system including prostate cancer.

The Veteran's death was caused by radiation, but the cause of his hematuria and prostate cancer is under review. The Board finds that VA did not obtain a proper medical opinion regarding the relationship between in-service asbestos exposure and the Veteran's death.

The Veteran's claims for service connection for various conditions have been granted. The claim for secondary service connection for hypertension is remanded.

The Board denied the Veteran's request for an earlier effective date for SMC based on housebound criteria prior to August 8, 2023. The Veteran was granted a TDIU in 2012 and later received a 100% evaluation for prostate cancer from August 8, 2023.

The Board has determined that the Veteran's claim for an increased disability rating for prostate cancer in remission with voiding dysfunction from January 1, 2026 must be remanded due to inadequate examination. The termination of the 100 percent disability rating for prostate cancer effective January 1, 2026 is upheld.

The Veteran's service-connected disabilities, including epilepsy, prostate cancer, and lumbar DDD, necessitate the need for regular aid and attendance from his spouse. The Board has granted SMC based on this need.

The Veteran's service connection claim for tonic-clonic seizures is denied as the evidence does not support a causal relationship to his military service or any service-connected disability. The Veteran's hypertension and prostate cancer residuals are also denied, with no compensable rating assigned due to lack of qualifying blood pressure readings.

The Veteran's service-connected disabilities do not render him unemployable, as his previous work experience and skills are sufficient to support a substantially gainful occupation.

The Veteran's prostate cancer is being remanded due to the AOJ failing to properly develop his claim for exposure to contaminated water at Camp Lejeune and herbicide exposure.

The Veteran's appeal for service connection of prostate cancer has been dismissed due to his death during the pendency of the appeal.

The Board has determined that the Veteran's erectile dysfunction is related to his service-connected prostate cancer and remands the case for further development.

The Veteran's prostate cancer was not incurred or aggravated during service, and there is no evidence of exposure to Agent Orange. The Board denied the claim for service connection.

The Veteran's service connection claims for Parkinson's disease, diabetes mellitus, type II, prostate cancer, and hypertension are granted on a presumptive basis due to herbicide agent exposure during active service. The claim for service connection for stroke is remanded.

The Veteran's prostate cancer claim is being remanded due to insufficient evidence regarding herbicide exposure and a need for further development of the claims file.

The Board has determined that the Veteran's diagnosed prostate cancer is as likely as not related to his service, including exposure to contaminated water at Camp Lejeune. Therefore, service connection for prostate cancer is granted.

The Veteran's prostate cancer, erectile dysfunction, voiding dysfunction, and sarcoid type granuloma of the right upper lip are granted. The Veteran's bilateral hearing loss and left shoulder condition are denied.,Service connection for tinnitus is granted based on in-service noise exposure.

The Board has granted effective dates of May 23, 2023 for service connection for prostate cancer associated with herbicide exposure and erectile dysfunction related to the service-connected prostate cancer. Special monthly compensation based on loss of use of a creative organ is also granted as of this date.

The Board has denied the Veteran's claims for service connection for prostate cancer and diabetes mellitus type II. The claim for service connection for obstructive sleep apnea is remanded.